These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8139144)

  • 1. [Effect of recombinant atrial natriuretic peptide (r-ANP) on ischemic and cyclosporine-induced kidney damage in rats].
    Yoshida K; Kagebayashi Y; Saka T; Yoneda T; Tani M; Ota M; Okajima E; Ozono S; Hirao Y; Okajima E
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):123-9. PubMed ID: 8139144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
    Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
    Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of changes in glomerular filtration rate induced by atrial natriuretic peptide in the rat kidney.
    Caron N; Kramp R
    Exp Physiol; 1999 Jul; 84(4):689-96. PubMed ID: 10481226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of atrial natriuretic peptide on sodium homeostasis in experimental renal failure.
    Nitta K; Naruse M; Sanaka T; Tsuchiya K; Sugino N
    Jpn J Exp Med; 1989 Oct; 59(5):181-8. PubMed ID: 2533287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity.
    Capasso G; Rosati C; Ciani F; Giordano DR; Russo F; De Santo NG
    Am J Hypertens; 1990 Mar; 3(3):204-10. PubMed ID: 2138899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with verapamil and adenosine triphosphate-MgCl2 reduces cyclosporine nephrotoxicity.
    Sumpio B; Baue AE; Chaudry IH
    Surgery; 1987 Mar; 101(3):315-22. PubMed ID: 2950608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of acute cyclosporine nephrotoxicity by atrial natriuretic factor after ischemia in the rat.
    Gianello P; Ramboux A; Poelart D; Jamart J; Berbinschi A; Donckier J; Ketelslegers JM; Lambotte L; Squifflet JP; Alexandre GP
    Transplantation; 1989 Mar; 47(3):512-5. PubMed ID: 2522254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
    Saad SY; Najjar TA
    Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium entry-blockade with verapamil in cyclosporine A plus ischemia induced acute renal failure in rats.
    Iaina A; Herzog D; Cohen D; Gavendo S; Kapuler S; Serban I; Schiby G; Eliahou HE
    Clin Nephrol; 1986; 25 Suppl 1():S168-70. PubMed ID: 3708928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide enhances recovery from ischemia/reperfusion-induced renal injury in rats.
    Chujo K; Ueno M; Asaga T; Sakamoto H; Shirakami G; Ueki M
    J Biosci Bioeng; 2010 Jun; 109(6):526-30. PubMed ID: 20471588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function.
    Schafferhans K; Heidbreder E; Hummel S; Heidland A
    Z Kardiol; 1988; 77 Suppl 2():78-84. PubMed ID: 2970179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal vascular and excretory resistance to atrial natriuretic peptide in pre-cirrhotic, bile-duct ligated rats.
    Valdivieso A; Boric MP; Riquelme A; Roblero J
    Biol Res; 1993; 26(3):397-404. PubMed ID: 7606260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between plasma atrial natriuretic peptide (ANP) and glomerular ANP receptors in 5/6 nephrectomized rats.
    Jin H; Yuan ZY; Du XH; Su G; Zhang L; Wang MX; Dong Y; Liu DX; Zou WZ; Wang SL
    Chin Med J (Engl); 1990 Oct; 103(10):794-9. PubMed ID: 2176581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
    Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S
    J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxicity of cyclosporine A in rats with a diminished renal function.
    Provoost AP; Kaptein L; Van Aken M
    Clin Nephrol; 1986; 25 Suppl 1():S162-7. PubMed ID: 3519023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
    Ma J; Peng A; Lin S
    Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atrial natriuretic peptide on arterial pressure and renal function in cirrhotic rats with ascites.
    López C; Jiménez W; Arroyo V; Gaya J; Rivera F; Rodés J
    Rev Esp Fisiol; 1988 Sep; 44(3):265-72. PubMed ID: 2976517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of synthetic rat-atrial natriuretic peptide in nephron-reduced rats with nephrotoxic nephritis.
    Nitta K; Sanaka T; Kawaguchi H; Tsuchiya K; Sone M; Takuma T; Sugino N
    Jpn J Exp Med; 1987 Feb; 57(1):41-5. PubMed ID: 2957529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies.
    Beutler JJ; Koomans HA; Bijlsma JA; Dorhout Mees EJ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1314-9. PubMed ID: 2148189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and pharmacodynamics of atrial natriuretic peptide and lithium clearance in the isolated perfused rat kidney.
    Brier ME; Brier RA; Luft FC; Aronoff GR
    J Pharmacol Exp Ther; 1987 Dec; 243(3):868-73. PubMed ID: 2961879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.